OrphoMed Appoints Gastroenterology Expert and Industry Veteran Mark Sostek, M.D. as Chief Medical Officer

SAN FRANCISCO, Jan. 4, 2018 -- (Healthcare Sales & Marketing Network) -- OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, today announced the appointment of Mark Sostek, M.D. as Chief Medical Officer... Biopharmaceuticals, Gastroenterology, Personnel OrphoMed, dimer therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news